CLXPF News and Press, Canadian Lynx Pete Ltd From 07/09/21

Research on psychedelics has shown that the substances possess various benefits , some of which can be used to manage mental health conditions such as anxiety, post-traumatic stress disorder and depression . In addition, in Canada individuals who are nearing the end of their lives have bee...

Yarygin/iStock via Getty Images Recently, a bill to decriminalize psychedelic substances has passed the California state Senate on a 21-16 vote. Senate Bill 519 would allow those aged 21 years and older to possess psilocybin (magic mushrooms) for personal use and “social sharing.&...

Cybin (NEO: CYBN) (OTCQB: CLXPF) , a biotechnology company focused on progressing psychedelic therapeutics, is increasing its focus and research activities in Europe. The company announced that it is working with several academic and clinical research organizations as part of those efforts,...

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will be participating in a panel discus...

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced the scaling up of its European operations and research activities with various acade...

Palm Beach, FL – July 7, 2021 – Psychedelic drugs and therapies are truly becoming mainstream and are expected to become even more so in the years to come. Psychedelic drugs involve various types of chemical substances including LSD and chemical extracted from plants. Psychede...

The coronavirus pandemic has affected economies and industries around the world, and while things seem to be getting back on track in some sectors, frontline workers still remain the most affected by COVID-19, which has caused millions to die. Data from a poll conducted by EClinicalMedici...

CYBN continues to demonstrate good progress with its preclinical activities on its novel drug programs, report observed Stifel also notes selecting indications with large patient pools, an understated market size, and potential for multiple synergies across development and distribution ...

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has entered into an exclusive research and development collaboration agreeme...

This is Psychedellux – the weekly recap of the business news in the psychedelics industry. Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) released financial and business highlights for its financial year ended March 31, 2021. The company noted that it h...